Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CASTOR2 (Cytosolic arginine sensor for mTORC1 subunit 2) is a cytosolic protein that serves as a negative regulator of the mTORC1 signaling pathway by sensing cellular arginine levels. It is structurally related to CASTOR1 but differs functionally; unlike CASTOR1, CASTOR2 does not bind arginine and constitutively associates with the GATOR2 complex[3]. CASTOR2 forms homodimers or heterodimers with CASTOR1, and these complexes interact with GATOR2 to inhibit mTORC1 activation in response to amino acid levels. CASTOR2 is part of a critical regulatory network controlling cell growth and metabolism via mTORC1 signaling, with potential relevance in cancer and other diseases characterized by abnormal cell growth or nutrient sensing[3][5][4].
Not applicable; No drugs directly target CASTOR2. Pathway drugs (e.g., mTOR inhibitors like rapamycin) act downstream of CASTOR2 regulation[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic arginine sensor for mTORC1 subunit 2 (CASTOR2).